US EditionUS Pharmaceutical Giant Eli Lilly to Invest over US$1 Billion in India to Expand Manufacturing Capacity
Eli Lilly will create up to 1,500 jobs and strengthen global supply chains by investing $1 billion to expand manufacturing and quality oversight in Hyderabad.
- On October 6, 2025, Eli Lilly revealed plans to commit over $1 billion toward expanding its contract manufacturing operations in India, including establishing a new manufacturing and quality center in Hyderabad, Telangana.
- This investment follows Lilly's longstanding presence in India and reflects confidence in India as a global hub for capability building amid efforts to expand manufacturing and supply capacity.
- The company plans to set up a manufacturing facility along with a quality center, initiate immediate hiring of engineers and specialists, and recently launched a Global Capability Centre in Hyderabad’s Gachibowli.
- Patrik Jonsson expressed that the investment underscores strong confidence in India, while the Chief Minister of Telangana described Hyderabad as an emerging leader in healthcare innovation.
- This expansion enhances Lilly’s growing portfolio and reinforces Telangana’s reputation as a leading hub for advanced healthcare manufacturing and pharmaceutical production.
26 Articles
26 Articles
US pharmaceutical giant Eli Lilly to invest over US$1 billion in India to expand manufacturing capacity
Eli Lilly will invest more than US$1 billion in India in the coming years to boost manufacturing and supply through local drugmakers, the company said on Monday (Oct 6), as it seeks to tap into a skilled workforce to bolster its global manufacturing expansion.The collaborations aim to increase the availabilit
Telangana bags USD1 billion Eli Lilly investment for new pharma manufacturing plant - The Tribune
Telangana bags USD1 billion Eli Lilly investment for new pharma manufacturing plantHyderabad (Andhra Pradesh) [India] October 6 (ANI): In a major boost to Telangana's life sciences sector, US pharma giant Eli Lilly has announced a massive investment of over USD1 billion to set up a new manufacturing plant and quality centre in Hyderabad.
Eli Lilly to Invest $1 Billion in India Contract Manufacturing
Eli Lilly and Co. plans to invest more than $1 billion in India over the next few years to build new contract manufacturing capabilities in the South Asian nation, underscoring the US drugmaker’s push to bolster its global supply network.
Eli Lilly, maker of weight loss drug Mounjaro, to manufacture in Telangana, promises $1 billion investment
The firm will ‘begin recruitment for Hyderabad location, with openings across roles such as engineers, chemists, analytical scientists, quality control and assurance professionals and management positions’
US pharma major Eli Lilly to invest USD 1 billion in Telangana
Hyderabad: American pharmaceutical company Eli Lilly is set to invest USD 1 billion in Telangana to expand its manufacturing and global medicine supply capacity, the government said on Monday, October 6. The announcement was made after the company’s global delegation met chief minister A Revanth Reddy and IT minister D Sridhar Babu at the Integrated Command Control Centre on Monday, October 6. “Telangana secured a massive investment of USD 1 bn …
Eli Lilly to invest $1 billion in India for manufacturing and quality hub
Since 2020, Lilly has invested more than $55 billion globally in building, expanding, and acquiring manufacturing facilities to support medicines for diabetes, obesity, Alzheimer’s disease, cancer, autoimmune conditions, and other therapies.
Coverage Details
Bias Distribution
- 59% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
